Lessons Learned from COVID-19: Access & Harm Reduction
CME Educational Session with Q&A

Zoom Webinar • Tuesday, September 22, 6:30-7:30 PM

The COVID-19 pandemic has posed unique challenges for addiction treatment across Maryland and DC. In part one of this three part CME series, our panelists will focus on key principles and best practices for OUD treatment during the pandemic, and related harm reduction strategies. 

Participants in this educational session will be able to:

  • Describe 3 key principles in caring for patients with opioid use disorder (OUD) during COVID-19.
  • Apply 3 lessons learned from OUD clinical practices during COVID-19.
  • Identify 3 key practice-level questions to consider as COVID-19 crisis evolves.
  • Identify relevant harm reduction strategies during COVID-19.

After the close of this session at 7:30 PM, attendees are encouraged to stay on the line for virtual networking in small breakout groups, selected by region. 


AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1 AMA PRA Category 1 Credits™ available for each date: September 22, October 22 and November 19.

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The MD/DCSAM Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.